Roua A Alsubki (Roua Alsubki)

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 30

Top Topics

Toxoplasma Gondii

Immune Response

Top Venues

Current oncology (Toronto, Ont.)

Molecules (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Manish Dhawan, Ali A Rabaan, Mahmoud M Al Fawarah, Souad A Almuthree, Roua A Alsubki, Amal H Alfaraj, Mutaib Mosaued Mashraqi, Saleh A Alshamrani, Wesam A Abduljabbar, Ameen S S Alwashmi, Fatimah Al Ibrahim, Abdulmonem A Alsaleh, Faryal Khamis, Jameela Alsalman, Manish Sharma, Talhah Bin Emran
Updated Insights into the T Cell-Mediated Immune Response against SARS-CoV-2: A Step towards Efficient and Reliable Vaccines. Vaccines 11 (1) (2023)
A S Smiline Girija, Shoba Gunasekaran, Saman Habib, Mohammed Mubarak Aljeldah, Basim R Al Shammari, Ahmad A Alshehri, Ameen S S Alwashmi, Safaa A Turkistani, Abdulsalam Alawfi, Amer Mohammad Alshengeti, Mohammed Garout, Sara Alwarthan, Roua A Alsubki, Nouran M Moustafa, Ali A Rabaan
Prediction of Putative Epitope Peptides against BaeR Associated with TCS Adaptation in Acinetobacter baumannii Using an In Silico Approach. Medicina (Kaunas, Lithuania) 59 (2) (2023)
Ali A Rabaan, Hajir A Al Saihati, Rehab Bukhamsin, Muhammed A Bakhrebah, Majed S Nassar, Abdulmonem A Alsaleh, Yousef N Alhashem, Ammar Y Bukhamseen, Khalil Al-Ruhimy, Mohammed Alotaibi, Roua A Alsubki, Hejji E Alahmed, Saleh Al-Abdulhadi, Fatemah A Alhashem, Ahlam A Alqatari, Ahmed Alsayyah, Ramadan Abdelmoez Farahat, Rwaa H Abdulal, Ali H Al-Ahmed, Mohd Imran, Ranjan K Mohapatra
Application of CRISPR/Cas9 Technology in Cancer Treatment: A Future Direction. Current oncology (Toronto, Ont.) 30 (2) (2023)
Ali A Rabaan, Mohammed Mubarak Aljeldah, Basim R Al Shammari, Roua A Alsubki, Jawaher M Al-Otaibi, Yousef N Alhashem, Neda A Alali, Tarek Sulaiman, Zainab Alsalem, Huda A Bajunaid, Mohammed Garout, Heba A Alsaffar, Souad A Almuthree, Doha Hudhaiah, Azhar M Alzaher, Fatimah A Alshaikh, Amer Mohammad Alshengeti, Mustafa A Najim, Ramadan Abdelmoez Farahat, Ranjan K Mohapatra
Epigenetic Targets and Pathways Linked to SARS-CoV-2 Infection and Pathology. Microorganisms 11 (2) (2023)
Majjid A Qaria, Chunyan Xu, Ran Hu, Roua A Alsubki, Mohamed Yassin Ali, Sethupathy Sivasamy, Kotb A Attia, Daochen Zhu
Ectoine Globally Hypomethylates DNA in Skin Cells and Suppresses Cancer Proliferation. Marine drugs 21 (12) (2023)
Ali A Rabaan, Mohammed Mubarak Aljeldah, Basim R Al Shammari, Roua A Alsubki, Jawaher M Al-Otaibi, Yousef N Alhashem, Neda A Alali, Tarek Sulaiman, Zainab Alsalem, Huda A Bajunaid, Mohammed Garout, Heba A Alsaffar, Souad A Almuthree, Doha Hudhaiah, Azhar M Alzaher, Fatimah A Alshaikh, Amer Mohammad Alshengeti, Mustafa A Najim, Ramadan Abdelmoez Farahat, Ranjan K Mohapatra
Epigenetic Targets and Pathways Linked to SARS-CoV-2 Infection and Pathology. Microorganisms 11 (2) (2023)
Ali A Rabaan, Mohammed Mubarak Aljeldah, Basim R Al Shammari, Roua A Alsubki, Jawaher M Al-Otaibi, Yousef N Alhashem, Neda A Alali, Tarek Sulaiman, Zainab Alsalem, Huda A Bajunaid, Mohammed Garout, Heba A Alsaffar, Souad A Almuthree, Doha Hudhaiah, Azhar M Alzaher, Fatimah A Alshaikh, Amer Mohammad Alshengeti, Mustafa A Najim, Ramadan Abdelmoez Farahat, Ranjan K Mohapatra
Epigenetic Targets and Pathways Linked to SARS-CoV-2 Infection and Pathology. Microorganisms 11 (2) (2023)
Ali A Rabaan, Hajir A Al Saihati, Rehab Bukhamsin, Muhammed A Bakhrebah, Majed S Nassar, Abdulmonem A Alsaleh, Yousef N Alhashem, Ammar Y Bukhamseen, Khalil Al-Ruhimy, Mohammed Alotaibi, Roua A Alsubki, Hejji E Alahmed, Saleh Al-Abdulhadi, Fatemah A Alhashem, Ahlam A Alqatari, Ahmed Alsayyah, Ramadan Abdelmoez Farahat, Rwaa H Abdulal, Ali H Al-Ahmed, Mohd Imran, Ranjan K Mohapatra
Application of CRISPR/Cas9 Technology in Cancer Treatment: A Future Direction. Current oncology (Toronto, Ont.) 30 (2) (2023)
Ali A Rabaan, Hajir A Al Saihati, Rehab Bukhamsin, Muhammed A Bakhrebah, Majed S Nassar, Abdulmonem A Alsaleh, Yousef N Alhashem, Ammar Y Bukhamseen, Khalil Al-Ruhimy, Mohammed Alotaibi, Roua A Alsubki, Hejji E Alahmed, Saleh Al-Abdulhadi, Fatemah A Alhashem, Ahlam A Alqatari, Ahmed Alsayyah, Ramadan Abdelmoez Farahat, Rwaa H Abdulal, Ali H Al-Ahmed, Mohd Imran, Ranjan K Mohapatra
Application of CRISPR/Cas9 Technology in Cancer Treatment: A Future Direction. Current oncology (Toronto, Ont.) 30 (2) (2023)
A S Smiline Girija, Shoba Gunasekaran, Saman Habib, Mohammed Mubarak Aljeldah, Basim R Al Shammari, Ahmad A Alshehri, Ameen S S Alwashmi, Safaa A Turkistani, Abdulsalam Alawfi, Amer Mohammad Alshengeti, Mohammed Garout, Sara Alwarthan, Roua A Alsubki, Nouran M Moustafa, Ali A Rabaan
Prediction of Putative Epitope Peptides against BaeR Associated with TCS Adaptation in Acinetobacter baumannii Using an In Silico Approach. Medicina (Kaunas, Lithuania) 59 (2) (2023)
Ali A Rabaan, Mohammed Mubarak Aljeldah, Basim R Al Shammari, Roua A Alsubki, Jawaher M Al-Otaibi, Yousef N Alhashem, Neda A Alali, Tarek Sulaiman, Zainab Alsalem, Huda A Bajunaid, Mohammed Garout, Heba A Alsaffar, Souad A Almuthree, Doha Hudhaiah, Azhar M Alzaher, Fatimah A Alshaikh, Amer Mohammad Alshengeti, Mustafa A Najim, Ramadan Abdelmoez Farahat, Ranjan K Mohapatra
Epigenetic Targets and Pathways Linked to SARS-CoV-2 Infection and Pathology. Microorganisms 11 (2) (2023)
Majjid A Qaria, Chunyan Xu, Ran Hu, Roua A Alsubki, Mohamed Yassin Ali, Sethupathy Sivasamy, Kotb A Attia, Daochen Zhu
Ectoine Globally Hypomethylates DNA in Skin Cells and Suppresses Cancer Proliferation. Marine drugs 21 (12) (2023)
Manish Dhawan, Ali A Rabaan, Mahmoud M Al Fawarah, Souad A Almuthree, Roua A Alsubki, Amal H Alfaraj, Mutaib Mosaued Mashraqi, Saleh A Alshamrani, Wesam A Abduljabbar, Ameen S S Alwashmi, Fatimah Al Ibrahim, Abdulmonem A Alsaleh, Faryal Khamis, Jameela Alsalman, Manish Sharma, Talhah Bin Emran
Updated Insights into the T Cell-Mediated Immune Response against SARS-CoV-2: A Step towards Efficient and Reliable Vaccines. Vaccines 11 (1) (2023)
Ali A Rabaan, Hajir A Al Saihati, Rehab Bukhamsin, Muhammed A Bakhrebah, Majed S Nassar, Abdulmonem A Alsaleh, Yousef N Alhashem, Ammar Y Bukhamseen, Khalil Al-Ruhimy, Mohammed Alotaibi, Roua A Alsubki, Hejji E Alahmed, Saleh Al-Abdulhadi, Fatemah A Alhashem, Ahlam A Alqatari, Ahmed Alsayyah, Ramadan Abdelmoez Farahat, Rwaa H Abdulal, Ali H Al-Ahmed, Mohd Imran, Ranjan K Mohapatra
Application of CRISPR/Cas9 Technology in Cancer Treatment: A Future Direction. Current oncology (Toronto, Ont.) 30 (2) (2023)
Ali A Rabaan, Hajir A Al Saihati, Rehab Bukhamsin, Muhammed A Bakhrebah, Majed S Nassar, Abdulmonem A Alsaleh, Yousef N Alhashem, Ammar Y Bukhamseen, Khalil Al-Ruhimy, Mohammed Alotaibi, Roua A Alsubki, Hejji E Alahmed, Saleh Al-Abdulhadi, Fatemah A Alhashem, Ahlam A Alqatari, Ahmed Alsayyah, Ramadan Abdelmoez Farahat, Rwaa H Abdulal, Ali H Al-Ahmed, Mohd Imran, Ranjan K Mohapatra
Application of CRISPR/Cas9 Technology in Cancer Treatment: A Future Direction. Current oncology (Toronto, Ont.) 30 (2) (2023)
Manish Dhawan, Ali A Rabaan, Mahmoud M Al Fawarah, Souad A Almuthree, Roua A Alsubki, Amal H Alfaraj, Mutaib Mosaued Mashraqi, Saleh A Alshamrani, Wesam A Abduljabbar, Ameen S S Alwashmi, Fatimah Al Ibrahim, Abdulmonem A Alsaleh, Faryal Khamis, Jameela Alsalman, Manish Sharma, Talhah Bin Emran
Updated Insights into the T Cell-Mediated Immune Response against SARS-CoV-2: A Step towards Efficient and Reliable Vaccines. Vaccines 11 (1) (2023)
Majjid A Qaria, Chunyan Xu, Ran Hu, Roua A Alsubki, Mohamed Yassin Ali, Sethupathy Sivasamy, Kotb A Attia, Daochen Zhu
Ectoine Globally Hypomethylates DNA in Skin Cells and Suppresses Cancer Proliferation. Marine drugs 21 (12) (2023)
Ali A Rabaan, Leonard Ighodalo Uzairue, Amal H Alfaraj, Muhammad A Halwani, Muzaheed Muzaheed, Abdulsalam Alawfi, Amer Mohammad Alshengeti, Nawal A Al Kaabi, Eman Alawad, Mashael Alhajri, Sara Alwarthan, Abeer N Alshukairi, Souad A Almuthree, Roua A Alsubki, Nada N Alshehri, Mohammed Alissa, Hawra Albayat, Tasneem I Zaidan, Hassan Alagoul, Ali Al Fraij, Jeehan H Alestad
Seroprevalence, Risk Factors and Maternal-Fetal Outcomes of Toxoplasma gondii in Pregnant Women from WHO Eastern Mediterranean Region: Systematic Review and Meta-Analysis. Pathogens (Basel, Switzerland) 12 (9) (2023)
Ayman Elbehiry, Eman Marzouk, Ihab M Moussa, Sulaiman Anagreyyah, Abdulaziz AlGhamdi, Ali Alqarni, Ahmed Aljohani, Hassan A Hemeg, Abdulaziz M Almuzaini, Feras Alzaben, Adil Abalkhail, Roua A Alsubki, Ali Najdi, Nawaf Algohani, Banan Abead, Bassam Gazzaz, Akram Abu-Okail
Using Protein Fingerprinting for Identifying and Discriminating Methicillin Resistant Staphylococcus aureus Isolates from Inpatient and Outpatient Clinics. Diagnostics (Basel, Switzerland) 13 (17) (2023)
A S Smiline Girija, Shoba Gunasekaran, Saman Habib, Mohammed Mubarak Aljeldah, Basim R Al Shammari, Ahmad A Alshehri, Ameen S S Alwashmi, Safaa A Turkistani, Abdulsalam Alawfi, Amer Mohammad Alshengeti, Mohammed Garout, Sara Alwarthan, Roua A Alsubki, Nouran M Moustafa, Ali A Rabaan
Prediction of Putative Epitope Peptides against BaeR Associated with TCS Adaptation in Acinetobacter baumannii Using an In Silico Approach. Medicina (Kaunas, Lithuania) 59 (2) (2023)
Ali A Rabaan, Hajir A Al Saihati, Rehab Bukhamsin, Muhammed A Bakhrebah, Majed S Nassar, Abdulmonem A Alsaleh, Yousef N Alhashem, Ammar Y Bukhamseen, Khalil Al-Ruhimy, Mohammed Alotaibi, Roua A Alsubki, Hejji E Alahmed, Saleh Al-Abdulhadi, Fatemah A Alhashem, Ahlam A Alqatari, Ahmed Alsayyah, Ramadan Abdelmoez Farahat, Rwaa H Abdulal, Ali H Al-Ahmed, Mohd Imran, Ranjan K Mohapatra
Application of CRISPR/Cas9 Technology in Cancer Treatment: A Future Direction. Current oncology (Toronto, Ont.) 30 (2) (2023)
Majjid A Qaria, Chunyan Xu, Ran Hu, Roua A Alsubki, Mohamed Yassin Ali, Sethupathy Sivasamy, Kotb A Attia, Daochen Zhu
Ectoine Globally Hypomethylates DNA in Skin Cells and Suppresses Cancer Proliferation. Marine drugs 21 (12) (2023)
Ali A Rabaan, Rehab Bukhamsin, Hajir A Al Saihati, Saleh A Alshamrani, Jehad AlSihati, Hani M Al-Afghani, Roua A Alsubki, Abdulmonem A Abuzaid, Saleh Al-Abdulhadi, Yahya Aldawood, Abdulmonem A Alsaleh, Yousef N Alhashem, Jenan A Almatouq, Talhah Bin Emran, Shamsah H Al-Ahmed, Firzan Nainu, Ranjan K Mohapatra
Recent Trends and Developments in Multifunctional Nanoparticles for Cancer Theranostics. Molecules (Basel, Switzerland) 27 (24) (2022)
Ali A Rabaan, Abbas Al Mutair, Saad Alhumaid, Mohammed Garout, Roua A Alsubki, Fatimah S Alshahrani, Wadha A Alfouzan, Jeehan H Alestad, Abdullah E Alsaleh, Maha A Al-Mozaini, Thoyaja Koritala, Sultan Alotaibi, Mohammad-Hani Temsah, Ali Akbar, Rafiq Ahmad, Zainab Khalid, Javed Muhammad, Naveed Ahmed
Updates on Measles Incidence and Eradication: Emphasis on the Immunological Aspects of Measles Infection. Medicina (Kaunas, Lithuania) 58 (5) (2022)
Ali A Rabaan, Saad Alhumaid, Hawra Albayat, Mohammed Alsaeed, Fadwa S Alofi, Mawaheb H Al-Howaidi, Safaa A Turkistani, Salah M Alhajri, Hejji E Alahmed, Abdulwahab B Alzahrani, Mutaib Mosaued Mashraqi, Sara Alwarthan, Mashael Alhajri, Fatimah S Alshahrani, Souad A Almuthree, Roua A Alsubki, Abdulmonem A Abuzaid, Mubarak Alfaresi, Mona A Al Fares, Abbas Al Mutair
Promising Antimycobacterial Activities of Flavonoids against Mycobacterium sp. Drug Targets: A Comprehensive Review. Molecules (Basel, Switzerland) 27 (16) (2022)
Ali A Rabaan, Rehab Bukhamsin, Hajir A Al Saihati, Saleh A Alshamrani, Jehad AlSihati, Hani M Al-Afghani, Roua A Alsubki, Abdulmonem A Abuzaid, Saleh Al-Abdulhadi, Yahya Aldawood, Abdulmonem A Alsaleh, Yousef N Alhashem, Jenan A Almatouq, Talhah Bin Emran, Shamsah H Al-Ahmed, Firzan Nainu, Ranjan K Mohapatra
Recent Trends and Developments in Multifunctional Nanoparticles for Cancer Theranostics. Molecules (Basel, Switzerland) 27 (24) (2022)
Ali A Rabaan, Rehab Bukhamsin, Hajir A Al Saihati, Saleh A Alshamrani, Jehad AlSihati, Hani M Al-Afghani, Roua A Alsubki, Abdulmonem A Abuzaid, Saleh Al-Abdulhadi, Yahya Aldawood, Abdulmonem A Alsaleh, Yousef N Alhashem, Jenan A Almatouq, Talhah Bin Emran, Shamsah H Al-Ahmed, Firzan Nainu, Ranjan K Mohapatra
Recent Trends and Developments in Multifunctional Nanoparticles for Cancer Theranostics. Molecules (Basel, Switzerland) 27 (24) (2022)
Ali A Rabaan, Muhammed A Bakhrebah, Hajir A Al Saihati, Saad Alhumaid, Roua A Alsubki, Safaa A Turkistani, Saleh Al-Abdulhadi, Yahya Aldawood, Abdulmonem A Alsaleh, Yousef N Alhashem, Jenan A Almatouq, Ahlam A Alqatari, Hejji E Alahmed, Dalal A Sharbini, Arwa F Alahmadi, Fatimah Alsalman, Ahmed Alsayyah, Abbas Al Mutair
Artificial Intelligence for Clinical Diagnosis and Treatment of Prostate Cancer. Cancers 14 (22) (2022)
Ali A Rabaan, Rehab Bukhamsin, Hajir A Al Saihati, Saleh A Alshamrani, Jehad AlSihati, Hani M Al-Afghani, Roua A Alsubki, Abdulmonem A Abuzaid, Saleh Al-Abdulhadi, Yahya Aldawood, Abdulmonem A Alsaleh, Yousef N Alhashem, Jenan A Almatouq, Talhah Bin Emran, Shamsah H Al-Ahmed, Firzan Nainu, Ranjan K Mohapatra
Recent Trends and Developments in Multifunctional Nanoparticles for Cancer Theranostics. Molecules (Basel, Switzerland) 27 (24) (2022)
Mohammad A Alfhili, Jawaher Alsughayyir, Ahmed M Basudan, Roua A Alsubki, Saleh Alqahtani, Zuhier Ahmed Awan, Mohammed R Algethami, Yazeed A Al-Sheikh
Monocyte-Lymphocyte Ratio and Dysglycemia: A Retrospective, Cross-Sectional Study of the Saudi Population. Healthcare (Basel, Switzerland) 10 (11) (2022)